Clinical Trials19 July 2023· 6 min read
New Alzheimer's Drug Donanemab Offers Hope for Treating Dementia
A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored by pharmaceutical com
By Tom Okafor, Clinical Trials Correspondent